Cargando…
Greenlight laser (XPS(TM)) 180W prostatectomy for treatment of benign prostate hyperplasia in patients with uncorrectable bleeding tendency
OBJECTIVES: Safety of GreenLight™ laser prostatectomy (GL-LP) in patients with ongoing blood thinners has been proven. Yet, the possibility of drug manipulation makes it a less challenging situation compared to treating patients with uncorrectable bleeding tendency. Herein, we aim at evaluating the...
Autores principales: | Elshal, Ahmed M., Ghobrial, Fady K., Laymon, Mahmoud, Elegeezy, Mohamed, El-Nahas, Ahmed R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208207/ https://www.ncbi.nlm.nih.gov/pubmed/37234681 http://dx.doi.org/10.1080/2090598X.2022.2156655 |
Ejemplares similares
-
Minimally invasive simple prostatectomy in the era of laser enucleation for high-volume prostates: A systematic review and meta-analysis
por: Abi Chebel, Josselin, et al.
Publicado: (2020) -
Oral desmopressin in nocturia with benign prostatic hyperplasia: A systematic review of the literature
por: Taha, Diaa-Eldin, et al.
Publicado: (2018) -
The role of Rezum in the management of refractory urinary retention due to benign prostate hyperplasia: A literature review
por: Khalil, Ibrahim A., et al.
Publicado: (2023) -
Transperineal intraprostatic injection of botulinum neurotoxin A vs transurethral resection of prostate for management of lower urinary tract symptoms secondary to benign prostate hyperplasia: A prospective randomised study
por: El-Dakhakhny, Amr S., et al.
Publicado: (2019) -
Global experience and progress in GreenLight-XPS 180-Watt photoselective vaporization of the prostate
por: Lichy, Isabel, et al.
Publicado: (2022)